These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 18300871

  • 1. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
    Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G.
    J Hypertens; 2008 Mar; 26(3):583-8. PubMed ID: 18300871
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption.
    Fukuda M, Wakamatsu-Yamanaka T, Mizuno M, Miura T, Tomonari T, Kato Y, Ichikawa T, Miyagi S, Shirasawa Y, Ito A, Yoshida A, Kimura G.
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F953-7. PubMed ID: 21865265
    [Abstract] [Full Text] [Related]

  • 3. Circadian rhythm and postural change in natriuresis in non-dipper type of essential hypertension.
    Uzu T, Takeji M, Yamauchi A, Kimura G.
    J Hum Hypertens; 2001 May; 15(5):323-7. PubMed ID: 11378834
    [Abstract] [Full Text] [Related]

  • 4. Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley rats.
    Endo S, Mori T, Yoneki Y, Nakamichi T, Hosoya T, Ogawa S, Tokudome G, Hosoya T, Miyata T, Ito S.
    Hypertens Res; 2009 Jun; 32(6):513-9. PubMed ID: 19407824
    [Abstract] [Full Text] [Related]

  • 5. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients.
    Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR.
    Chronobiol Int; 2009 Jan; 26(1):61-79. PubMed ID: 19142758
    [Abstract] [Full Text] [Related]

  • 6. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy.
    Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, Yoshida A, Kimura G.
    Kidney Int; 2004 Feb; 65(2):621-5. PubMed ID: 14717933
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
    Smolensky MH, Hermida RC, Portaluppi F.
    Chronobiol Int; 2007 Feb; 24(1):171-81. PubMed ID: 17364587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M, Korhonen M, Litmanen H, Niskanen L, Väisänen S, Rauramaa R.
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [Abstract] [Full Text] [Related]

  • 10. Short-term analysis of the relationship between blood pressure and urinary sodium excretion in normotensive subjects.
    Centonza L, Castoldi G, Chianca R, Busca G, Golin R, Zanchetti A, Stella A.
    Clin Sci (Lond); 2000 Apr; 98(4):495-500. PubMed ID: 10731486
    [Abstract] [Full Text] [Related]

  • 11. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis.
    Fukuda M, Motokawa M, Miyagi S, Sengo K, Muramatsu W, Kato N, Usami T, Yoshida A, Kimura G.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2172-7. PubMed ID: 16627609
    [Abstract] [Full Text] [Related]

  • 12. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
    Uzu T, Sakaguchi M, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, Araki SI, Sugiomoto T, Koya D, Haneda M, Kashiwagi A.
    Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
    [Abstract] [Full Text] [Related]

  • 13. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension.
    Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, Inenaga T, Kimura G.
    Am J Kidney Dis; 1999 Jan; 33(1):29-35. PubMed ID: 9915264
    [Abstract] [Full Text] [Related]

  • 14. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM, Lao GC, Xu G, Xie B, Zhang Y, Liu W, Feng Q, Guo J.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 10; 88(22):1557-61. PubMed ID: 18956640
    [Abstract] [Full Text] [Related]

  • 15. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.
    Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.
    J Hypertens; 2005 Apr 10; 23(4):861-5. PubMed ID: 15775792
    [Abstract] [Full Text] [Related]

  • 16. Circadian blood pressure rhythm is disturbed by nephrectomy.
    Goto N, Uchida K, Morozumi K, Ueki T, Matsuoka S, Katayama A, Haba T, Tominaga Y, Fukuda M, Nakao A, Kimura G.
    Hypertens Res; 2005 Apr 10; 28(4):301-6. PubMed ID: 16138559
    [Abstract] [Full Text] [Related]

  • 17. Patients with renal dysfunction require a longer duration until blood pressure dips during the night.
    Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, Miyagi S, Yoshida A, Kimura G.
    Hypertension; 2008 Dec 10; 52(6):1155-60. PubMed ID: 18936344
    [Abstract] [Full Text] [Related]

  • 18. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
    Resnick LM, Catanzaro D, Sealey JE, Laragh JH.
    Am J Hypertens; 2004 Mar 10; 17(3):203-8. PubMed ID: 15001191
    [Abstract] [Full Text] [Related]

  • 19. Effect of olmesartan on oxidative stress in hemodialysis patients.
    Kadowaki D, Anraku M, Tasaki Y, Kitamura K, Wakamatsu S, Tomita K, Gebicki JM, Maruyama T, Otagiri M.
    Hypertens Res; 2007 May 10; 30(5):395-402. PubMed ID: 17587751
    [Abstract] [Full Text] [Related]

  • 20. Abnormal blood pressure circadian rhythm in acute ischaemic stroke: are lacunar strokes really different?
    Castilla-Guerra L, Espino-Montoro A, Fernández-Moreno MC, López-Chozas JM.
    Int J Stroke; 2009 Aug 10; 4(4):257-61. PubMed ID: 19689751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.